News & Events
News articles, press releases and events Innoblative is attending
Committed to innovative surgical solutions for improved tissue coagulation and ablation, enhancing patient care.
News & Press Releases
Innoblative Announces Successful First-in-Human Use of its Novel Electrosurgical Device for Breast Cancer Treatment
CHICAGO, July 16, 2024 /PRNewswire/ — Innoblative Designs, Inc. (Innoblative), a private medical device company addressing clinical unmet needs for patients with breast cancer, announced today that it has initiated its first-in-human clinical experience, successfully treating a 64-year-old patient with stage II luminal A
Innoblative Designs: Revolutionizing Post-Lumpectomy Treatment
July 27, 2023 /Medtech Outlook/ – “Our mission is to develop and commercialize novel products to intraoperatively ablate surgical margins post-excision for treating early-stage breast cancer. Developed by a team of surgeons and graduate students at Northwestern University, our SIRAT™
Innoblative Receives U.S. FDA Breakthrough Device Designation for its SIRA RFA Electrosurgical Device
Novel device is designed specifically for patients undergoing breast-conserving surgery (BCS) for breast cancer CHICAGO, April 27, 2023 /PRNewswire/ — Innoblative Designs, Inc. (Innoblative), a private medical device company addressing clinical unmet needs for patients with breast cancer, announced today that it received Breakthrough
Innoblative Welcomes Kelly Londy as Chief Executive Officer
CHICAGO, Sept. 4, 2019 /PRNewswire/ — Innoblative Designs, Inc. (Innoblative), a private medical device company committed to developing next generation, advanced-energy surgical solutions, including its recently FDA cleared SIRA™ RFA Electrosurgical Device, today announced the appointment of Kelly Londy as Chief Executive Officer. “We are delighted to
Innoblative’s SIRA™ RFA Electrosurgical Device Receives FDA Clearance
CHICAGO, April 9, 2019 /PRNewswire/ — Innoblative Designs, Inc. (Innoblative), a private medical device company committed to developing next generation, advanced-energy surgical solutions, announced it received U.S. Food and Drug Administration (FDA) clearance for its SIRA™ RFA Electrosurgical Device, a novel radiofrequency ablation (RFA) applicator
Upcoming & Past Events
Join Us at the 26th Annual Meeting of the American Society of Breast Surgeons (ASBrS) 2025
When: April 30 – May 4, 2025 Location: Bellagio Hotel in Las Vegas, NV Details: Join us at the 26th Annual Meeting of the American Society
Join Us at RESI JPM 2025
When: January 14, 2025 Location: San Francisco, CA Details: The 50th RESI Conference will be held on January 14 at the San Francisco Marriott Marquis, featuring an in-person
Join Us at the MedTech Strategist Innovation Summit
When: November 19-21, 2024 Location: US Grant Hotel in San Diego, CA Details: The MedTech Strategist Innovation Summit is an influential medical technology event that has brought
Join Us at Breastanbul 2024 For An Exclusive Symposium on Innovative Breast Cancer Treatments
When: October 11, 2024 – 16:00 – 16:30 Location: Wyndham Grand Istanbul, Hall A Symposium Title:De-escalation of Radiation for Low-Risk Breast Cancer Using Intraoperative Ablation – Is
Join Us at The 43rd Congress of the European Society of Surgical Oncology (ESSO)
When: October 2-4, 2024 Location: Antwerp, Belgium Learn more here
Join Us at LSI Europe ’24
When: September 16 – 20, 2024 Location: Ritz-Carlton Penha Longa Resort in Sintra, Portugal Details: LSI Europe ’24 is MedTech’s premier partnering event that will bring
